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With the realization that many retroviruses exploit a low-pH entry mechanism, the 1 method of endocytosis utilized by the viruses has been examined. Avian sarcoma and leukosis 2 virus B (ASLV-B) enters through clathrin-coated pits, whereas ASLV-A entry requires intact 3 lipid rafts for efficient entry (20, 48) . While HIV principally enters cells through direct fusion 4 with the plasma membrane (44), HIV has been shown to productively enter CD4 expressing 5
HeLa cells through clathrin-mediated endocytosis, and into polarized trophoblastic cells through 6 a clathrin-, caveolin-, and dynamin-independent endocytosis event (18, 71). The pH-7 independence of fusion events associated with amphotropic MLV had led investigators to believe 8 that fusion occurred at the plasma membrane, but amphotropic MLV has since been shown to 9 enter cells through caveolae endocytosis (2, 20, 48) . Hence, within this single family of viruses, 10 individual family members have evolved to utilize several different cellular mechanisms 11 presumably in order to most effectively take advantage of their targeted cellular receptor. 12
The lentivirus, equine infectious anemia virus (EIAV), is responsible for the first 13 described retroviral-mediated disease and was one of the first filterable agents described (37, 69) . 14 Although the disease that EIAV causes was initially characterized more than 150 years ago, little 15 is known about its mechanism of entry. In vivo EIAV is primarily if not exclusively macrophage 16 tropic; however, in tissue culture the virus is able to adapt to infect additional cell-types 17 including endothelial cells and fibroblasts from not only equine species, but from feline and 18 canine origin as well (52, 61) . Changes within the long terminal repeat and envelope are 19 associated with both altered virulence and cell tropism (13, 41, 55) . Interaction with the cellular 20 receptor, equine lentiviral receptor 1 (ELR1) has been demonstrated to be responsible for EIAV 21 internalization (74). EIAV entry into both primary cells and tissue culture cell lines has recently 22 been shown to be dependent on a low-pH step (10, 31) implicating a requirement for endocytosis 23 of the virus. However, the mechanism of endocytosis mediating productive entry of EIAV has 24 not been investigated. 25
In this study we examine the pathway of EIAV internalization using the low-pH-26 dependent, tissue culture strain of EIAV . Parallel studies were performed to determine the 27
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on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from internalization pathway used by a variant, superinfecting strain of EIAV that enters cells it 1 superinfects in a pH-independent manner (10, 42) . Entry of EIAV MA-1 that is representative of 2 wild-type strains of EIAV was inhibited by treatments that blocked the formation of clathrin-3 coated pits. In contrast, entry of the superinfecting strain EIAV vMA-1c into target cells that it 4 superinfects was not inhibited by these same treatments; however, inhibition of actin cytoskeletal 5 rearrangements decreased entry. These latter findings indicate that EIAV vMA-1c superinfection 6 does not require the same endocytosis pathway as wild-type EIAV and suggests that this variant 7 virus is able to fuse with the plasma membrane of those target cells. 8
on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from endocytosis inhibitors and pseudotyped particles were added. Forty hours following 1 transduction, the cells were fixed in 3.7% formalin and evaluated for β-galactosidase activity 2 using the substrate X-gal. The number of β-galactosidase positive cells was enumerated by 3 microscopic visual inspection. 4
Internalization assay. ED cells were incubated with virions or pseudotyped particles at 4°C for 5 1 hr to allow virus binding, but not internalization. The virus containing media was replaced 6 with fresh ED media and shifted to 37°C. At various time points following 37°C shift, cells were 7 treated with citric acid buffer (40 mM citric acid, 10 mM KCl, 135 mM NaCl, pH 3.0) for 1 min 8 to inactivate any particles that remained on the surface. The cells were washed 2 times with 9 media to remove the acidic buffer, and fresh ED media was added. Cells were fixed and stained 10 for either EIAV antigens or β-galactosidase activity 40 hr following infection and the number of 11 positive cells was determined. Control values represent the number of positive cells when there 12 was no citric acid wash. 13 Cellular membrane fractionation. 5 x 10 5 ED cells were trypsized and aliquoted into 14 microfuge tubes. Media was added and cells were incubated at 37°C for 1 hr to allow re-15 expression of plasma membrane proteins. Cells pelleted and resuspended in ice cold media in the 16 presence or absence of EIAV (EIAV MA-1 or EIAV vMA-1c ). Cells were held for 1 hr on ice and 17 washed with ice cold PBS twice to remove unbound virus. Separation of detergent insoluble 18 membranes was performed as previously described (49). Cells were lysed on ice with lysis 19 buffer (1% Brij, 150 mM NaCl and 10 mM Tris (pH 7.5)) for 50 min. Nycodenz media (70% 20 Nycodenz, 20 mM Tris (pH 7.5), 150 mM NaCl) was added to the lysed cells for a final 21 concentration of 38.75% Nycodenz and this was layered under a Nycodenz step gradient was 22 generated in a sterile polycarbonate ultracentrifuge tube by adding 200 µl each of 25%, 22.5%, 23 20%, 18%, 15%, 12% and 8% Nycodenz media to the top of the lysed cell mixture. Tubes were 24 centrifuged for 4 hr at 200,000 x g at 4°C and stopped without a brake. Two hundred microliter 25 aliquots were collected from the top of the tube and stored at -80°C until analyzed by 26 immunoblotting. 27 Cathepsin inhibitors. Cathepsin L inhibitor (CalBiochem #219402) and a pan-cathepsin 4 inhibitor (CalBiochem #219419) were resuspended in DMSO at 10mM stock. Cathepsin 5 inhibitors were diluted into media and preincubated with cells for 1 hr. The cells were infected 6 in the presence of the drug and the cathepsin inhibitor containing inoculum was removed 16 hr 7 following infection and fresh media was replaced. 8
Cell viability assay. ED cells were plated and treated with drugs as described above. Forty 9 hours following treatment cell viability was monitored by ATPLite Assay (Packard Biosciences) 10 per manufacturer's instructions. 11
ED cell transfection with Eps15 constructs. ED cells were transfected with a control 12
Eps15D3∆2-GFP fusion protein (7), or a dominant negative Eps15∆95-295-GFP (5) expression 13 plasmid using Amaxa transfection reagents. Briefly, 1.5 million ED cells were resuspended in 14 100 µL Amaxa Solution T containing 5 µg of plasmid DNA. ED cells were electroporated using Statistical analysis. All studies were performed at least three independent times. Means and 1 standard errors of the mean are shown. Student's t-test was used to evaluate the statistical 2 differences between treatments, utilizing the two-tailed distribution and two-sample equal 3 variance conditions. P-values were accessed by comparing the level of infectivity with treatment 4 to the level of cytoxicity seen with that treatment. A significant difference was determined by a 5 p-value of < 0.05 and significance was identified in each figure. If the p-value was > 0.05 the 6 data were not considered significant. 7
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Results
1
EIAV internalization occurs rapidly. Viral entry kinetics provide insights into the pathway(s) 2 of internalization. Clathrin-mediated endocytosis is known to occur very quickly after ligand 3 binding, whereas caveolae uptake occurs more slowly (16, 39) . Documented examples of this 4 are the clathrin-mediated internalization of VSVG pseudotyped particles that occurs in minutes, 5 whereas caveolae-mediated internalization of amphotropic murine leukemia virus requires hours 6 (2). To examine the kinetics of EIAV internalization, a tissue culture derived strain of EIAV, 7 EIAV MA-1 , was bound to equine dermal cells (ED cells) at 4°C for one hour. The unbound virus 8 and supernatant were removed, replaced with warmed cell media and shifted to 37°C to promote 9 internalization. At various time points following the temperature shift, the cells were washed 10 with citric acid to inactivate virion particles that had not been internalized. Cells were examined 11 for EIAV antigen expression 40 hours after infection. Internalization of EIAV MA-1 occurred 12 rapidly, with 50% of the virions internalized within 1 hour (Fig. 1) . VSVG pseudotyped EIAV 13 particle entry occurred at a similar rate. These data are consistent with previously published 14 internalization kinetics for virions and ligands that enter through clathrin-coated pits (2, 16). The 15 variant strain EIAV vMA-1c that has been shown to primarily enter ED cells through a pH-16 independent pathway resulting in superinfection (10) was observed to have a similar, rapid rate 17 of uptake. 18
Wild-type EIAV, but not EIAV vMA-1c , is dynamin dependent. Dynamin is a GTPase required 19 for the cellular membrane to pinch off endosomes from the plasma membrane and is needed for 20 clathrin and caveolae-mediated endocytosis and phagocytosis, but it is not required for 21 macropinocytosis (25, 27, 63) . Dominant negative dynamin (DNdyn1(K44A)) has decreased 22
GTPase activity that results in reduced endocytosis (26, 70) . While dynamin 2 is ubiquitously 23 expressed in cells, dynamin 1 is specific for neuronal cells (63) . However, over expression of 24 the dominant negative K44A mutation of either dynamin 1 or 2 has been shown to impact 25 endocytosis in a variety of cells (21, 53, 62, 63) . Utilizing adenoviral transducing particles that 26 express either GFP or DNdyn1(K44A), followed by EIAV infection or VSVG pseudotyped 27 virion transduction, we were able to test the dynamin dependence of EIAV infection. An 1 adenoviral MOI of 10 transduced more than 94% of the ED cells as evidenced by GFP 2 expression (data not shown) and the same MOI was used for all the adenoviral transductions. 3 VSVG pseudotyped MLV particle entry has been previously shown to be inhibited by DNdyn 4 thus VSVG pseudotyped EIAV particles were used as a positive control (35). EIAV MA-1 entry 5 was significantly inhibited by expression of DNdyn1 (Fig. 2) . Similar trends were seen with 6 expression of DNdyn2 (data not shown), but DNdyn2 expression in ED cells resulted in high 7 levels of cell toxicity. EIAV vMA-1c entry into ED cells was not affected by DNdyn1 suggesting 8 that neither clathrin-coated pits nor caveolae are important for entry of EIAV vMA-1c into these 9
cells. 10
A role for actin rearrangement in EIAV vMA-1c entry, but not in EIAV MA-1 entry. Actin 11 rearrangement is necessary for some endocytosis mechanisms such as caveolae-mediated uptake 12 and macropinocytosis as well as direct virus fusion with the plasma membrane (12, 38, 66) . In 13 order to determine if EIAV entry requires an intact actin cytoskeleton we utilized cytochalasin D 14 (cytoD), a drug that depolymerizes actin (38). Immunofluorescence images of actin staining 15 demonstrate that the concentrations of cytoD used effectively depolymerized the actin network in 16 ED cells (data not shown). As with some of the other endocytosis inhibitors used in this study, 17 cytoD was cytotoxic and caused cells to round-up and detach from the surface of the plate. 18
Consequently, cell viability assays were performed to measure the impact of the drug on the cells 19 over the 40 h experiment. The effect of cytoD on EIAV entry was evaluated and results were 20 compared to the drugs impact on cell viability. VSVG dependent transduction is not affected by 21 cytoD and served as a negative control whereas EBOV glycoprotein dependent entry is 22 dependent on actin polymerization and served as a positive control (11, 73) . EIAV MA-1 entry 23 diminished by cytoD in a dose dependent manner, in parallel a loss of cell viability occurred 24 (Fig. 3A) . The decrease in entry mediated by both EIAV MA-1 and VSVG glycoproteins could be 25 accounted for by the loss of cell numbers in the culture dish. EBOV-GP mediated entry, into 26 SNB-19 cells, was significantly decreased when compared to the cell viability (Fig. 3A) . The 27 EBOV GP transduction studies were performed in SNB-19 cells because ED cells were not 1 permissive for EBOV GP dependent transduction. We concluded that actin depolymerization 2 does not directly impact entry of EIAV MA-1 . Despite the loss of cells in the presence of cytoD, 3 low concentrations of cytoD appeared to slightly enhance EIAV vMA-1c entry into ED cells, but 4 this was not statistically significant. 5
Signal transduction events mediated by tyrosine kinases induce actin rearrangements and 6 can play a role in caveolae endocytosis (54, 57). These events can be blocked by the tyrosine 7 kinase inhibitor genistein (GEN) (57). Inhibition of tyrosine kinase activity by GEN also inhibits 8 HIV-1 entry into primary macrophages by preventing virus fusion with the plasma membrane 9 (67). EIAV MA-1 and EIAV vMA-1c , entry into ED cells was examined in the presence of GEN 10 ( (Fig. 4A) . 21
Similar treatment of SNB-19 cells inhibited EBOV-GP mediated entry that has previously been 22
shown to be dependent on lipid rafts (23) . 23
To further demonstrate efficacy of MβCD at the concentrations used in this study, we 24 sought to determine if viral particles treated with MβCD to eliminate cholesterol from the viral 25 membrane would reduce infectivity. Other retroviruses such as HIV-1 have been shown to bud 26 through lipid rafts and the cholesterol in the viral membrane is important for viral infectivity (3, 27 36) . Virus was incubated with MβCD for one hour, diluted approximately 200 fold and added to 1 cells. This treatment effectively reduced the infectivity of HIV virions (more than 90% 2 decrease) known to require cholesterol in the viral membrane (data not shown). MβCD 3 treatment dramatically inhibited the entry of EIAV MA-1 and EIAV vMA-1c , but did not significantly 4 inhibit the transduction of VSVG pseudotyped particles (Fig. 4B) . 5 ELR1 is not present in lipid rafts. If lipid rafts are not important for EIAV entry, we would 6 anticipate that the cellular receptor for EIAV, Equine lentiviral receptor 1 (ELR1) would not 7 colocalize with detergent resistant membranes. Consequently, we next determined the location 8 of ELR1 within the plasma membrane both before and following virion binding. ED cells 9 incubated in the presence or absence of EIAV MA-1 virions at 4°C were lysed in a Brij lysis buffer 10 that solublizes the non-lipid raft membranes but keeps the lipid rafts intact. Cell lysates were 11 subjected to membrane floatation on a nycodenz gradient. Centrifugation caused the lipid raft-12 containing membranes to float to the top of the gradient whereas the solubilized proteins remain 13 at the bottom (28). The gradient was fractionated into 11 fractions and subjected to Western blot 14 analysis to determine which fraction contained ELR1 and EIAV proteins. Caveolin 1, a lipid raft 15 associated protein, was found in the detergent resistant fractions (Fig. 5A) , validating our 16 experimental protocol. EIAV capsid protein was found primarily, but not exclusively, in 17 fractions containing detergent resistant membranes when the virions were examined by 18 themselves or after they were bound to cells, suggesting that EIAV's lipid membrane contains 19 lipid rafts ( Fig. 5B and C) . EIAV matrix protein was observed in similar fraction (data not 20 shown). ELR1 was only found in the lower fractions that are not associated with detergent 21 resistant membranes, suggesting the protein was solubulized by the lysis buffer and was not 22 found in lipid rafts even after virus binding (Fig. 5B) . 23
Because membrane fluidity is reduced at 4°C, the experiment was repeated with an 24 additional 37°C incubation. Once virus was bound to cells at 4°C, the cells were shifted to 37°C 25 for 20, 40, or 60 minutes, lysed, and membrane floatation was performed. The ELR1 protein 26 was found in the soluble fractions at each time frame (Fig. 5D) , indicating that ELR1 does not 27 shown to be inhibited by the drug chlorpromazine (CPZ) (63) . CPZ redirects the adapter 6 proteins that bind to the plasma membrane proteins to internal membranes, preventing clathrin-7 mediated endocytosis from the cell surface (72). VSVG is known to enter through clathrin-8 mediated endocytosis (68), and therefore was utilized as a positive control. ED cells were 9 treated with increasing amounts of CPZ and examined for their ability to inhibit EIAV entry. 10 EIAV MA-1 virus was inhibited in a dose dependent manner (Fig. 6A) . Although the drug had 11 some cytotoxicity, levels of EIAV MA-1 entry were significantly reduced as compared to 12 chlorpromazine's impact on cell viability suggesting that wild type EIAV enters cells through a 13 clathrin-mediated pathway. CPZ did not impact EIAV vMA-1c entry into ED cells. 14 The clathrin pit associated protein Eps15 serves as a linker between the clathrin coat and 15 the receptor being internalized (6, 29). A dominant negative form of Eps15 (DN-Eps15∆95-295) 16 lacks the Eps homology domains that are necessary for clathrin-coated pit targeting, and thus 17 inhibits clathrin uptake (5). ED cells were transfected with GFP, Eps15D3∆2-GFP that does not 18 interfere with clathrin uptake (6, 29), or DNEps15∆95-295-GFP and infected with EIAV MA-1 or 19 EIAV vMA-1c 24 hours after transfection. Expression of the DN-Eps15∆95-295-GFP fusion 20 protein followed by infection with EIAV MA-1 confirmed that clathrin endocytosis is required for 21 EIAV entry (Fig. 6B) . The transfected cells were 57-65%.GFP positive at 24 h following 22 transfection demonstrating good efficiency of transfection. EIAV vMA-1c only showed minor 23 inhibition, similar to the slight inhibition seen when a low-pH entry pathway is blocked during 24 EIAV vMA-1c infection (10). These findings are consistent with the CPZ findings that EIAV vMA-1c 25
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does not require clathrin for entry into ED cells. 26
To understand whether entry via clathrin-mediated endocytosis occurs with other strains 1 of EIAV, the infectivity of four additional strains of EIAV were examined in the presence of 2 CPZ. These EIAV strains, that have previously been shown to enter cells through a low pH-3 dependent mechanism, were inhibited by CPZ in a dose dependent manner (Fig. 6C) . These 4 strains included EIAV WSU5 that retains the ability to infected horses, suggesting that both tissue-5 culture adapted strains and field isolates enter ED cells through clathrin-mediated endocytosis. EIAV vMA-1c were significantly inhibited (Fig. 7A) . Consistent with low pH-dependent entry of 13 both EIAV MA-1 and EIAV vMA-1c entry into eUVEC cells was inhibited in a dose dependent 14 manner by CPZ (Fig. 7B) . 15
Cathepsin inhibitors do not inhibit EIAV entry.
Recently, the entry of several low pH-16 dependent viruses has been shown to require viral glycoprotein processing by cellular, low pH-17 dependent endosomal proteases such as cathepsins (60, 64). To determine if wild-type EIAV's 18 requirement for low-pH entry is dependent on glycoprotein processing by cellular cathepsin 19 proteases, we infected ED cells in the presence of a pan-cathepsin inhibitor as well as a specific 20 cathepsin L inhibitor. EBOV pseudotyped particles serve as a positive control for these studies 21 whereas VSVG transduction serves as a negative control. Cathepsin L is a ubiquitously 22 expressed protease and has been shown to be involved in Ebolavirus entry (60). Both the pan-23 cathepsin and cathepsin L inhibitor had no effect on EIAV MA-1 or EIAV vMA-1c entry (Fig. 8A and  24 
B). The cathepsin B inhibitor CA-074Me also did not inhibit EIAV entry into ED cells (data not 25 shown). 26
To further demonstrate that cathepsin L does not play a role in EIAV entry, we performed 1 an in vitro protease cleavage assay. Viral particles were incubated in a low-pH acetate buffer 2 with purified cathepsin L. Virions were analyzed by immunoblotting to determine if proteolysis 3 of the glycoprotein had occurred. There was no detectable decrease in full length glycoprotein 4 and no cleavage products detected with EIAV MA-1 or EIAV vMA-1c but the Ebolavirus glycoprotein 5 was efficiently cleaved (Fig. 8C) . These findings indicate that EIAV glycoprotein does not 6 require a low pH step for proteolytic processing, but perhaps for glycoprotein conformational 7 changes that are needed to generate a fusion ready state. 8
Discussion 1
In summary, we present data that the wild-type EIAV MA-1 infects cells through clathrin-2 mediated endocytosis. The clathrin pathway was important for EIAV MA-1 entry into both the ED 3 cell line and primary eUVEC cells. We also demonstrated that several other strains of EIAV 4 enter ED cells through clathrin-coated pits. The low-pH requirement for EIAV entry is not 5 required for glycoprotein cleavage by cellular endosomal proteases. Instead, we propose that the 6 acidic conditions may be altering the conformation of the intact surface protein and thereby 7 facilitating conditions that allow fusion to occur. In contrast, the superinfecting EIAV strain, 8 EIAV vMA-1c , does not require clathrin-mediated endocytosis, lipid rafts or dynamin, but active 9 actin remodeling enhances entry into ED cells suggesting that EIAV vMA-1c may fuse at the plasma 10 membrane. However, in UVECs that EIAV vMA-1c can not superinfect, the entry pathway appears 11 to be similar to that found for other EIAV strains. 12
The importance of actin remodeling in clathrin-mediated endocytosis remains 13
controversial. Some reports demonstrate dynamic actin polymerization is required for clathrin-14 mediated endocytosis (24), but other reports show that this requirement is cell type specific (24, 15 73). As others have observed for VSVG dependent entry (73), our study demonstrates a clathrin-16 dependent and actin remodeling independent entry of VSVG. In a similar manner, we propose 17 that wild-type EIAV also uses a clathrin-dependent and actin remodeling independent 18 mechanism for entry. 19
Conflicting data is present in the literature about VSVG mediated entry and dynamin 20 dependence. Entry of VSVG pseudotyped MLV particles was shown to be inhibited by 21 expression of dominant negative dynamin (K44A) (35). In contrast, recent report showed that 22 VSVG pseudotyped HIV particles were not inhibited by expression of a different mutant 23 dynamin (G273D) (18). Our results with the dynamin (K44A) are consistent with the earlier 24 study that used this same mutant and suggest that the discrepancy may be due to the different 25 dynamin mutants used or the cell type. 26
While the presence of cholesterol in target cells is not important for EIAV entry, loss of 1 cholesterol from the virion decreases virus infectivity. Other retroviruses such as HIV and 2 amphotropic MuLV have been shown to bud through lipid raft containing membranes (2, 36, 3 50) . Our data indicate that EIAV also buds through lipid raft domains in the plasma membrane. 4
In contrast to wild-type EIAV, the variant strain EIAV vMA-1c enters cells that it 5 superinfects via a pH-independent pathway (10). The absence of a low-pH requirement for ED 6 cell entry suggested that EIAV vMA-1c either fuses at the plasma membrane or enters through a pH-7 independent endocytosis mechanism. Studies presented here allow us to exclude internalization The low-pH requirement for productive entry of many viruses has been investigated (8, 1 14, 15, 19, 39, 40, 45, 47, 63) . Current evidence indicates that low-pH conditions are required to 2 alter the viral surface glycoprotein conformation and thereby remove its steric hindrance of 3 virus/cell fusion. Two different mechanisms of acid-induced conformational changes have been 4
identified. In the case of influenza virus, the conformation of the intact viral glycoprotein is 5 altered under low-pH conditions (65). In contrast, the viral surface glycoprotein of such viruses 6 as Ebolavirus and SARS is cleaved into small peptides by low-pH-activated cellular protease 7 activities (14, 60, 64 ). Here we demonstrate that EIAV entry is not inhibited by cathepsin 8 inhibitors and cathepsin L does not cleave the EIAV SU protein in vitro. Cathepsin independent, 9 low-pH-dependent surface glycoprotein alterations are consistent with our previously published 10 findings that a low-pH shock of virus bound cells increases infectivity (10). The increase in 11 infectivity at the cell surface suggests that there are no endosomal specific enzymatic activities 12 required for the fusion event to take place. 13
A previous study using a sucrose shock to block clathrin-dependent entry did not inhibit 14 entry of EIAV into ED cells leading the authors to conclude that EIAV entry was independent of 15 clathrin-mediated endocytosis (31). We also found that similar sucrose treatment did not affect 16 EIAV or VSVG entry into ED cells (data not shown). The findings from the sucrose studies are 17 inconsistent with our findings using more specific means of inhibiting the formation of clathrin-18 coated pits such as dominant negative Eps15 or chlorpromazine (63) . Therefore, we conclude 19 that under the conditions used the sucrose shock was not impacting clathrin-mediated entry. 20 
